| Bioactivity | TLR7/8 agonist 7 (compound 10) is a TLR7/8 agonist. TLR7/8 agonist 7 activates a variety of immune cells and it can be used to synthesize immune stimulating antibody conjugate (ISAC) molecules. TLR7/8 agonist 7 can be used for the research of immunity[1]. |
| Invitro | TLR7/8 agonist 7 (compound 10) (0-1 μΜ; 24 h) is a TLR7 agonist and shows selectivity to TLR7[1].TLR7/8 agonist 7 (compound 10) (0-1 μΜ; 120 h) shows no cytotoxicity to KB cells[1].TLR7/8 agonist 7 (compound 10) (0.01, 0.1, 1, 10, 100 and 1000 nM; 48 h) induces immune cells activation[1].TLR7/8 agonist 7 (compound 10) (0.1, 1, 10, 100 and 1000 nM; 24-48 h) induces cytokine release[1]. Cell Viability Assay[1] Cell Line: |
| Name | TLR7/8 agonist 7 |
| CAS | 2567953-47-1 |
| Formula | C26H37N7O2 |
| Molar Mass | 479.62 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Maderna, et al. 5H-PYRROLO[3,2-d]PYRIMIDINE-2,4-DIAMINO COMPOUNDS AND ANTIBODY CONJUGATES THEREOF. WO/2020/252043. |